Skip to main content
EnglishEN

Therapeutic potential of optimized derivatives of an endogenous CXCR4 antagonist for the treatment of cancers and inflammatory diseases

Project description

DEENESFRITPL

Novel drugs against cancer and inflammatory diseases

Fields of science

Programme(s)

Topic(s)

Call for proposal

ERC-2018-PoC

See other projects for this call

Funding Scheme

ERC-POC - Proof of Concept Grant

Host institution

UNIVERSITAET ULM
Net EU contribution
€ 95 256,00
Address
Helmholtzstrasse 16
89081 Ulm
Germany

See on map

Region
Baden-Württemberg Tübingen Ulm, Stadtkreis
Activity type
Higher or Secondary Education Establishments
Links
Other funding
€ 0,00

Beneficiaries (3)

UNIVERSITAET ULM
Germany
Net EU contribution
€ 95 256,00
Address
Helmholtzstrasse 16
89081 Ulm

See on map

Region
Baden-Württemberg Tübingen Ulm, Stadtkreis
Activity type
Higher or Secondary Education Establishments
Links
Other funding
€ 0,00
FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG EV
Germany
Net EU contribution
€ 26 950,00
Address
Hansastrasse 27c
80686 Munchen

See on map

Region
Bayern Oberbayern München, Kreisfreie Stadt
Activity type
Research Organisations
Links
Other funding
€ 0,00
UNIVERSITE DE STRASBOURG
France
Net EU contribution
€ 26 950,00
Address
Rue Blaise Pascal 4
67081 Strasbourg

See on map

Region
Grand Est Alsace Bas-Rhin
Activity type
Higher or Secondary Education Establishments
Links
Other funding
€ 0,00

Share this page

Download

EC signature date: 22 August 2018
Last update: 19 August 2022
Record number: 218459

My Booklet

Permalink: https://cordis.europa.eu/project/id/813081

© European Union, 2023